That does not seem to be what the practice is now, right?

It has changed.

I mean, I think we're about the same age.

That's what I learned too in medical school.

And the practice has changed, I think, for several reasons.

One, there have been several large randomized comparative effectiveness trials, looking at the early initiation of carbidopa levodopa and comparing it to other medication classes that might have a lower rate of dyskinesias, which is what people were quite worried about early on, or even no treatment.

And the levodopa group has better quality of life for a longer period of time if you start it early.

And then you realize it doesn't work and you give them the clonazepam, which is what usually happens to